Astec Lifesciences Share Price | Astec Lifesciences Stock Screener
ASTEC
Pesticides & Agrochemicals
Share Price NSE
₹659.10
▼
-6.45 (-0.97%)
Share Price BSE
₹659.10
▼
-6.65 (-1.00%)
As of July 24, 2026, the Astec Lifesciences share price (NSE: ASTEC) is ₹659.10 on NSE and ₹659.10 on BSE, down 0.97% from the previous close, with shares trading between ₹638.05 and ₹667.00, and a 52-week range of ₹521.85–₹918.75.
Analyse ASTEC share price charts and track historical price performance.
Use the Astec Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Astec Lifesciences Market Cap
₹1,514.56 Cr.
ASTEC P/E Ratio (TTM)
-18.87
Astec Lifesciences P/B Ratio
3.91
EPS (TTM)
₹-37.79
Dividend Yield
-
Debt to Equity
1.60
ASTEC 52 Week High
₹918.75
Astec Lifesciences 52 Week Low
₹521.85
Operating Margin
6.00%
Profit Margin
-4.97%
ASTEC Revenue (TTM)
₹161.00
EBITDA
₹12.00
Net Income
₹-8.00
Total Assets
₹942.00
Total Equity
₹391.00
Astec Lifesciences Share Price Chart
Screen Astec Lifesciences share price with an interactive chart. Analyse ASTEC price trends and volatility across different timeframes.
Astec Lifesciences Company Profile - Fundamental Screener
Screen Astec Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ASTEC shares.
Sector
Chemicals
Industry
Pesticides & Agrochemicals
Sub-Sector
Pesticides & Agrochemicals
Segment
E
ISIN
INE563J01010
Astec Lifesciences Balance Sheet Screener
Screen ASTEC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 942 | 881 | 975 | 979 | 897 | 678 | 572 | 461 | 413 | 334 |
| Current Assets | 443 | 341 | 399 | 499 | 516 | 330 | 332 | 249 | 232 | 198 |
| Fixed Assets | 459 | 499 | 386 | 319 | 340 | 213 | 194 | 167 | 115 | 103 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 51 | 281 | 208 | 34 | 10 | 46 | 7 | 10 | 5 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 391 | 235 | 370 | 420 | 397 | 309 | 247 | 203 | 170 | 138 |
| Share Capital | 22 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
| Reserves & Surplus | 368 | 215 | 350 | 400 | 377 | 290 | 227 | 183 | 150 | 119 |
Astec Lifesciences Income Statement Screener - Profit & Revenue Analysis
Screen Astec Lifesciences income statement and profit fundamentals.
Analyze ASTEC quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Astec Lifesciences share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 161 | 126 | 75 | 92 | 120 | 96 | 101 | 70 | 156 | 52 | 112 | 145 | 130 | 121 | 204 |
| Expenses | 150 | 123 | 80 | 102 | 114 | 100 | 118 | 116 | 141 | 69 | 114 | 140 | 122 | 105 | 167 |
| EBITDA | 12 | 3 | -6 | -11 | 6 | -4 | -18 | -45 | 15 | -17 | -2 | 5 | 8 | 16 | 37 |
| Operating Profit % | 6.00% | 2.00% | -9.00% | -12.00% | 5.00% | -6.00% | -20.00% | -67.00% | 8.00% | -36.00% | -3.00% | 2.00% | 4.00% | 10.00% | 17.00% |
| Depreciation | 12 | 11 | 10 | 12 | 12 | 11 | 12 | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 8 |
| Interest | 8 | 7 | 8 | 11 | 10 | 10 | 9 | 7 | 7 | 6 | 6 | 7 | 6 | 6 | 5 |
| Profit Before Tax | -8 | -16 | -24 | -33 | -16 | -25 | -39 | -62 | -1 | -32 | -18 | -11 | -6 | 1 | 25 |
| Tax | 0 | 0 | 0 | 0 | 0 | 15 | 0 | -22 | 0 | -8 | -4 | -3 | -1 | 0 | 6 |
| Net Profit | -8 | -16 | -24 | -33 | -16 | -40 | -39 | -40 | -1 | -24 | -13 | -8 | -5 | 1 | 18 |
| EPS | -3.48 | -7.04 | -11.35 | -16.85 | -8.20 | -20.59 | -19.66 | -20.26 | -0.50 | -12.41 | -6.85 | -4.18 | -2.54 | 0.43 | 9.34 |
Astec Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen ASTEC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -81 | -8 | 10 | 75 | 24 | -8 | 168 | 15 | 65 | 19 |
| Investing Activities | -4 | -15 | -135 | -113 | -104 | -73 | -74 | -53 | -49 | -18 |
| Financing Activities | 95 | 24 | 125 | 38 | 81 | 81 | -95 | 37 | -18 | -1 |
| Net Cash Flow | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | 1 |
Astec Lifesciences Shareholding Pattern Screener
See Astec Lifesciences shareholding pattern with promoter, FII, and DII holdings.
Check Astec Lifesciences promoter holding and ownership changes for ASTEC on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Jul | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.97% | 70.87% | 70.87% | 72.42% | 72.42% | 71.97% | 66.75% | 66.75% |
| FII Holding | 0.02% | 0.25% | 0.02% | 0.02% | 0.00% | 0.04% | 1.25% | 1.03% |
| DII Holding | 3.34% | 4.34% | 4.26% | 4.01% | 4.01% | 3.17% | 7.88% | 3.38% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.81% | 19.62% | 19.98% | 18.96% | 19.32% | 20.87% | 19.62% | 22.52% |
| Other Holding | 3.86% | 4.91% | 4.87% | 4.59% | 4.25% | 3.95% | 4.49% | 6.33% |
| Shareholder Count | 21,041 | 18,689 | 18,549 | 18,889 | 18,276 | 22,293 | 19,848 | 19,955 |
Astec Lifesciences Share Dividend Screener - Share Yield Analysis
Check Astec Lifesciences dividend history with payout and yield data.
View Astec Lifesciences dividend details including ex-dates and amounts for ASTEC stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹1.50 | 0.14% |
| 2022-March | ₹1.50 | 0.11% |
| 2021-March | ₹1.50 | 0.09% |
| 2020-March | ₹1.50 | 0.15% |
| 2019-March | ₹1.50 | 0.39% |
| 2018-March | ₹1.50 | 0.28% |
| 2017-March | ₹1.50 | 0.26% |
Astec Lifesciences Stock Index Membership
See which indices include Astec Lifesciences stock.
Check ASTEC index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX CARBON
BSE INDEX SMLCAP
Astec Lifesciences Market Events Screener - Corporate Actions
Get Astec Lifesciences corporate actions including splits, bonuses, and buybacks.
Check Astec Lifesciences stock events that may affect ASTEC share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-31 | 2026-07-31 | Annual General Meeting | NA | -5.20% |
| 2026-04-27 | 2026-04-27 | Quarterly Result Announcement | NA | -3.59% |
| 2026-01-30 | 2026-01-30 | Quarterly Result Announcement | NA | -12.93% |
| 2025-10-29 | 2025-10-29 | Quarterly Result Announcement | NA | -8.59% |
| 2025-07-28 | 2025-07-28 | Annual General Meeting | NA | 18.90% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 0.28% |
| 2025-07-04 | 2025-07-04 | Rights | 1:7 | 1.17% |
| 2025-04-23 | 2025-04-23 | Quarterly Result Announcement | NA | 8.19% |
| 2025-01-27 | 2025-01-27 | Quarterly Result Announcement | NA | -5.28% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -2.20% |
| 2024-07-29 | 2024-07-29 | Annual General Meeting | NA | -0.11% |
| 2023-07-27 | 2023-07-27 | Annual General Meeting | NA | -6.19% |
| 2023-07-21 | 2023-07-22 | Dividend | ₹ 1.50 /share | -2.96% |
| 2022-07-19 | 2022-07-21 | Dividend | ₹ 1.50 /share | 13.10% |
| 2021-07-22 | 2021-07-24 | Dividend | ₹ 1.50 /share | 19.13% |
Astec Lifesciences Competitors Screener - Peer Comparison
Screen ASTEC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| UPL | 52,001 | 23.02 | 52,502 | 11.41% | 2,220 | 50.77 |
| PI Industries | 40,783 | 30.53 | 6,714 | -19.33% | 1,361 | 48.12 |
| Sumitomo Chemical | 26,847 | 49.73 | 3,385 | 3.56% | 543 | 68.24 |
| Bayer Crop Science | 19,550 | 27.78 | 5,593 | 7.89% | 568 | 55.08 |
| Sharda Cropchem | 7,953 | 11.72 | 5,410 | 23.53% | 681 | 42.65 |
| NACL Industries | 4,931 | 1047.00 | 1,587 | 27.74% | 5 | 51.35 |
| Dhanuka Agritech | 4,585 | 15.22 | 2,071 | 15.49% | 297 | 36.29 |
| Rallis | 4,508 | 31.33 | 2,631 | 6.54% | 164 | 58.90 |
| Bhagiradha Chemicals & Industries | 3,531 | 197.04 | 538 | 19.68% | 18 | 48.61 |
| GSP Crop Science | 2,310 | 24.02 | 1,517 | 16.60% | 91 | 71.24 |
Astec Lifesciences Company Announcements - News Screener
Screen ASTEC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-20 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-08 | Intimation Of Annual General Meeting And Annual Report Of Financial Year 2025-26 | - |
| 2026-07-08 | Closure Of Register Of Members And Share Transfer Book | - |
| 2026-07-08 | Reg. 34 (1) Annual Report. | - |
| 2026-07-08 | Intimation Of "Annual General Meeting" And Annual Report Of Financial Year 2025-26 | - |
| 2026-07-08 | Intimation Of "Annual General Meeting" And Annual Report Of Financial Year 2025-26 | - |
| 2026-07-04 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-07-04 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-07-04 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-04 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-07-04 | Postal Ballot | - |
| 2026-06-27 | Closure of Trading Window | - |
| 2026-06-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-06-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-02 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-06-01 | Reply On Significant Increase In The Volume Of Security | - |
| 2026-06-01 | Clarification Sought from Astec Lifesciences Ltd | - |